Navigation Links
Canadian Company Develops Subconscious Screening Technology

OTTAWA, Canada, Sept. 21 /PRNewswire/ -- The National Mental Health Association reports that over 65 million Americans suffer from some type of mental illness and that 1 in 5 people will experience some mental illness during their life. By 2020, mental illness is projected to be the leading cause of disease burden in North America, an obviously staggering problem with total costs to society running into the hundreds of billions every year. Northam Psychotechnologies, a Canadian-based company, holds the North American patent pending to futuristic technologies that provide a profoundly powerful solution to this impending problem.

Semantic Stimuli Response Measurement (SSRM) is one of many powerful psychological screening tools they have developed. It is the world's first technology designed and utilized to meticulously measure the response of the subconscious mind outside of a laboratory setting. Internationally renowned brain researcher Dr. Semyon Ioffe has adapted and further developed this technology, which is the direct result of a worldwide body of scientific knowledge, to accommodate the North American conglomerate. He states, "We are the first testing and teaching technology company in the area of mental health, and are able to effectively test for and detect early stages of mental disorders. We also test the effectiveness of medical or psychological treatment for mental disorders, and teach patients, on a subconscious level, to free themselves from drug and alcohol addictions, phobias, suicidal tendencies, PTSD and so much more."

SSRM Tek can effectively enhance treatment accuracy and efficacy by determining the root causes of mental afflictions. Treatment times are significantly reduced. Unnecessary treatment methods are eliminated and the results generated are virtually error-free. "SSRM Tek easily obtains invaluable information from a source that never lies: the subconscious mind," Dr. Ioffe states further. "This technology has been in development for over five decades. It has surfaced strongly now and is the future of mental health care standards." He goes on to explain how SSRM Tek is even being implemented in the war in Afghanistan.

SSRM Tek can determine the effectiveness of treatment being provided to patients. Concurrent testing and re-testing can determine if treatment is having positive effects on the patient and can follow up on the progress of the treatment. As the world's first technology to measure the response of the subconscious mind, this precise psychological screening tool can be used broadly in the world of business and security as well as health. Dr. Ioffe concludes, "We encourage people to request further information about how SSRM Tek can transform the modern world around us, shattering any preconceived notions you may have about the human psyche."

About Northam Psychotechnologies: Northam Psychotechnologies is an integrated solutions provider advocating SSRM Tek in promoting solutions for security, defense and health, scientifically measuring the traditionally immeasurable: the subconscious mind. Northam Psychotechnologies was founded by Dr. Semyon Ioffe, a widely published and esteemed researcher in the field of "Psycho-Semantics."

Northam Psychotechnologies | Detection | Identification | Treatment


Dr. Semyon Ioffe

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at

SOURCE Northam Psychotechnologies
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Curemark Attends North American Bio Forum at Canadian Government Invitation
2. Neurochip technology developed by Canadian team
3. Vineland shows Canadian leadership with response to G20
4. The iBridge Network Adds Torontos University Health Network as First Canadian Partner
5. New Canadian solar photovoltaic research network established; based at McMaster University
6. Dow AgroSciences, Monsanto Complete U.S. and Canadian Regulatory Authorizations for SmartStax Corn; Plans Set to Launch Seed Platform on 3 Million- to 4 Million-Plus Acres
7. Canadian researchers discover gene related to the appearance of aging
8. BioMS Medical to present at the 2009 Symposium for the Canadian Society for Pharmaceutical Sciences
9. Canadian research team reports major breakthrough in lithium battery technology
10. DuPont Receives Canadian Regulatory Approval for High Oleic Soybean Trait
11. Vancouver General Hospital is the First Canadian Institution to Implement Copan WASP(R): Walk-Away Specimen Processor
Post Your Comments:
(Date:11/27/2015)... November 27, 2015 ... popularity of companion diagnostics is one of ... market with pharmaceutical companies and diagnostic manufacturers ... tests. . --> ... report on global cancer biomarkers market spread ...
(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: ... adopted a stockholder rights plan (Rights Plan) in an ... loss carryforwards (NOLs) under Section 382 of the Internal ... --> PharmAthene,s use of its NOLs could be ... as defined in Section 382 of the Code. In ...
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. ... Gorman , President and CEO of Neurocrine Biosciences, will ... Conference in New York . ... visit the website approximately 5 minutes prior to the ... replay of the presentation will be available on the ...
(Date:11/25/2015)... PORTLAND, Oregon , November 25, 2015 /PRNewswire/ ... Deep Market Research Report is a professional and ... Genomics industry.      (Logo: ... basic overview of the industry including definitions, classifications, ... analysis is provided for the international markets including ...
Breaking Biology Technology:
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... , Oct. 29, 2015  Connected health pioneer, ... driving the explosion of technology-enabled health and wellness, and ... new book, The Internet of Healthy Things ... sensors or smartphones even existed, Dr. Kvedar, vice president, ... of health care delivery, moving care from the hospital ...
Breaking Biology News(10 mins):